Cargando…
Long-term outcomes of polycythemia vera patients treated with ropeginterferon Alfa-2b
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9061291/ https://www.ncbi.nlm.nih.gov/pubmed/35210530 http://dx.doi.org/10.1038/s41375-022-01528-x |
| _version_ | 1784698698984325120 |
|---|---|
| author | Kiladjian, Jean-Jacques Klade, Christoph Georgiev, Pencho Krochmalczyk, Dorota Gercheva-Kyuchukova, Liana Egyed, Miklos Dulicek, Petr Illes, Arpad Pylypenko, Halyna Sivcheva, Lylia Mayer, Jiří Yablokova, Vera Krejcy, Kurt Empson, Victoria Hasselbalch, Hans C. Kralovics, Robert Gisslinger, Heinz |
| author_facet | Kiladjian, Jean-Jacques Klade, Christoph Georgiev, Pencho Krochmalczyk, Dorota Gercheva-Kyuchukova, Liana Egyed, Miklos Dulicek, Petr Illes, Arpad Pylypenko, Halyna Sivcheva, Lylia Mayer, Jiří Yablokova, Vera Krejcy, Kurt Empson, Victoria Hasselbalch, Hans C. Kralovics, Robert Gisslinger, Heinz |
| author_sort | Kiladjian, Jean-Jacques |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9061291 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-90612912022-05-04 Long-term outcomes of polycythemia vera patients treated with ropeginterferon Alfa-2b Kiladjian, Jean-Jacques Klade, Christoph Georgiev, Pencho Krochmalczyk, Dorota Gercheva-Kyuchukova, Liana Egyed, Miklos Dulicek, Petr Illes, Arpad Pylypenko, Halyna Sivcheva, Lylia Mayer, Jiří Yablokova, Vera Krejcy, Kurt Empson, Victoria Hasselbalch, Hans C. Kralovics, Robert Gisslinger, Heinz Leukemia Letter Nature Publishing Group UK 2022-02-24 2022 /pmc/articles/PMC9061291/ /pubmed/35210530 http://dx.doi.org/10.1038/s41375-022-01528-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Letter Kiladjian, Jean-Jacques Klade, Christoph Georgiev, Pencho Krochmalczyk, Dorota Gercheva-Kyuchukova, Liana Egyed, Miklos Dulicek, Petr Illes, Arpad Pylypenko, Halyna Sivcheva, Lylia Mayer, Jiří Yablokova, Vera Krejcy, Kurt Empson, Victoria Hasselbalch, Hans C. Kralovics, Robert Gisslinger, Heinz Long-term outcomes of polycythemia vera patients treated with ropeginterferon Alfa-2b |
| title | Long-term outcomes of polycythemia vera patients treated with ropeginterferon Alfa-2b |
| title_full | Long-term outcomes of polycythemia vera patients treated with ropeginterferon Alfa-2b |
| title_fullStr | Long-term outcomes of polycythemia vera patients treated with ropeginterferon Alfa-2b |
| title_full_unstemmed | Long-term outcomes of polycythemia vera patients treated with ropeginterferon Alfa-2b |
| title_short | Long-term outcomes of polycythemia vera patients treated with ropeginterferon Alfa-2b |
| title_sort | long-term outcomes of polycythemia vera patients treated with ropeginterferon alfa-2b |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9061291/ https://www.ncbi.nlm.nih.gov/pubmed/35210530 http://dx.doi.org/10.1038/s41375-022-01528-x |
| work_keys_str_mv | AT kiladjianjeanjacques longtermoutcomesofpolycythemiaverapatientstreatedwithropeginterferonalfa2b AT kladechristoph longtermoutcomesofpolycythemiaverapatientstreatedwithropeginterferonalfa2b AT georgievpencho longtermoutcomesofpolycythemiaverapatientstreatedwithropeginterferonalfa2b AT krochmalczykdorota longtermoutcomesofpolycythemiaverapatientstreatedwithropeginterferonalfa2b AT gerchevakyuchukovaliana longtermoutcomesofpolycythemiaverapatientstreatedwithropeginterferonalfa2b AT egyedmiklos longtermoutcomesofpolycythemiaverapatientstreatedwithropeginterferonalfa2b AT dulicekpetr longtermoutcomesofpolycythemiaverapatientstreatedwithropeginterferonalfa2b AT illesarpad longtermoutcomesofpolycythemiaverapatientstreatedwithropeginterferonalfa2b AT pylypenkohalyna longtermoutcomesofpolycythemiaverapatientstreatedwithropeginterferonalfa2b AT sivchevalylia longtermoutcomesofpolycythemiaverapatientstreatedwithropeginterferonalfa2b AT mayerjiri longtermoutcomesofpolycythemiaverapatientstreatedwithropeginterferonalfa2b AT yablokovavera longtermoutcomesofpolycythemiaverapatientstreatedwithropeginterferonalfa2b AT krejcykurt longtermoutcomesofpolycythemiaverapatientstreatedwithropeginterferonalfa2b AT empsonvictoria longtermoutcomesofpolycythemiaverapatientstreatedwithropeginterferonalfa2b AT hasselbalchhansc longtermoutcomesofpolycythemiaverapatientstreatedwithropeginterferonalfa2b AT kralovicsrobert longtermoutcomesofpolycythemiaverapatientstreatedwithropeginterferonalfa2b AT gisslingerheinz longtermoutcomesofpolycythemiaverapatientstreatedwithropeginterferonalfa2b AT longtermoutcomesofpolycythemiaverapatientstreatedwithropeginterferonalfa2b |